Abstract
This report will detail the current and projected market for wound management products, including
dressings, closure devices, debridement, pharmacological products, tissue engineered products and
others. Particular emphasis will be given to advanced or leading edge developments (i.e., those
approaching wound management from novel perspective) such as growth factors, stem cells, gene
therapy and other approaches, while baseline data (current and forecast market size and current
competitor market shares) will be provided for established segments such as conventional dressings
markets, though will be provided. The report will detail the clinical and technology developments
underlying this huge and evolving worldwide market, with data on products in development and on the
market; market size and forecast; competitor market shares; competitor profiles; and market
opportunity. Separate size, growth and competitor data will be presented for the U.S., leading
western European countries, Japan and the Rest of World category. The report will profile leading
and emerging companies, with equitable inclusion or exclusion of specific companies based on
consistent criteria. The company profiles will provide detailed profile information on 15-20 major
competitors, brief profiles of companies with less sizeable current or potential positions in the
market, and additional profiles of companies with novel or advanced research activities in the
market.
The report will establish the current worldwide market size for major technology segments as a
baseline for and projecting growth in the market over a ten-year forecast and will assess and
project the composition of the market as technologies gain or lose relative market performance over
this period. | 
View Cart
